SK Bio­science plans $261M ex­pan­sion in South Ko­rea with new fa­cil­i­ty

The South Ko­re­an vac­cine mak­er and biotech SK Bio­science will be ex­pand­ing close to home.

In an an­nounce­ment on Wednes­day, SK Bio­science said it would be con­struct­ing a re­search and process de­vel­op­ment cen­ter in Song­do, South Ko­rea, south­west of Seoul. SK Bio­science will be in­vest­ing $261 mil­lion in­to the over 327,000 square feet cen­ter, dubbed the R&PD cen­ter.

SK Bio­science said that the new cen­ter is ex­pect­ed to be com­plet­ed in the first half of 2025 and that its cur­rent R&D cen­ter in Pangyo, South Ko­rea, will move in­to the new fa­cil­i­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER